MTOR and pancreatic neoplasm: Similarly, alisertib (ALS), a potent and selective Aurora kinase A inhibitor, induces cell cycle arrest and autophagy and suppresses EMT involving PI3K/Akt/mTOR and SIRT1-mediated signaling pathways in human pancreatic cancer cells (177).